Food choice as a key management strategy for functional gastrointestinal symptoms

American Journal of Gastroenterology

Volumn 107, Issue 5, 2012, Pages 657-666

  Gibson, Peter R ^a   Shepherd, Susan J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; C REACTIVE PROTEIN; DISACCHARIDE; FRUCTOSE; GLUTAMIC ACID; GLUTEN; HLA DQB1 ANTIGEN; IMMUNOGLOBULIN G4; INTERLEUKIN 6; LACTOSE; LEUKOTRIENE; MONOSACCHARIDE; OLIGOSACCHARIDE; POLYSACCHARIDE; SALICYLIC ACID; SHORT CHAIN FATTY ACID; SORBITOL; VANILLOID RECEPTOR; VANILLOID RECEPTOR 1;

ABDOMINAL PAIN; ANAPHYLAXIS; ASTHMA; CELIAC DISEASE; DIETARY INTAKE; DIETITIAN; ENTERITIS; ENTEROENDOCRINE CELL; ENZYMATIC ASSAY; FOOD COMPOSITION; GASTROINTESTINAL SYMPTOM; GLUTEN FREE DIET; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTESTINE DISTENSION; INTESTINE FUNCTION DISORDER; INTESTINE INNERVATION; IRRITABLE COLON; LOW CARBOHYDRATE DIET; MICROFLORA; MOLECULAR SIZE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; URTICARIA; CARBOHYDRATE DIET; DIET THERAPY; INTESTINE ABSORPTION; METABOLISM; PATHOPHYSIOLOGY;

COLONIC DISEASES, FUNCTIONAL; DIET, GLUTEN-FREE; DIETARY CARBOHYDRATES; GLUTENS; HUMANS; INTESTINAL ABSORPTION;

EID: 84862311617     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.49     Document Type: Review

References (82)

1. Saito YA, Locke III GR, Weaver AL et al. Diet and functional gastrointestinal disorders: a population-based case-control study. Am J Gastroenterol 2005;100:2743-8.
2. Monsbakken KW, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome - etiology, prevalence and consequences. Eur J Clin Nutr 2006;60:667-72. (Pubitemid 43922887)
3. Jamieson AE, Fletcher PC, Schneider MA. Seeking control through the determination of diet: a qualitative investigation of women with irritable bowel syndrome and inflammatory bowel disease. Clin Nurse Spec 2007;21:152-60.
4. Mullin GE, Swift KM, Lipski L et al. Testing for food reactions: the good, the bad, and the ugly. Nutr Clin Pract 2010;25:192-8.
5. Kanazawa M, Fukudo S. Effects of fasting therapy on irritable bowel syndrome. Int J Behav Med 2006;13:214-20. (Pubitemid 44860228)
6. Dainese R, Galliani EA, De Lazzari F et al. Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol 1999;94:1892-7. (Pubitemid 29315906)
7. Bischoff SC, Herrmann A, Manns MP. Prevalence of adverse reactions to food in patients with gastrointestinal disease. Allergy 1996;51:811-8. (Pubitemid 26384215)
8. Niec AM, Frankum B, Talley NJ. Are adverse food reactions linked to irritable bowel syndrome? Am J Gastroenterol 1998;93:2184-90. (Pubitemid 29076872)
9. James SL, Muir JG, Curtis SL et al. Dietary fibre: a roughage guide. Intern Med J 2003;33:291-6.
10. Ford AC, Talley NJ, Spiegel BM et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. Br Med J 2008;337:a2313.
11. Brandt LJ, Chey WD, Foxx-Orenstein AE et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104 (Suppl 1):S1-S35.
12. Gibson PR, Newnham E, Barrett JS et al. Review article: fructose malabsorption and the bigger picture. Aliment Pharmacol Ther 2007;25:349-63. (Pubitemid 46184448)
13. Austin GL, Dalton CB, Hu Y et al. A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2009;7:706-8.
14. Sternini C, Anselmi L, Rozengurt E. Enteroendocrine cells: a site of "taste" in gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes 2008;15:73-8.
15. Schemann M, Mazzuoli G. Multifunctional mechanosensitive neurons in the enteric nervous system. Auton Neurosci 2010;153:21-5.
16. Boesmans W, Owsianik G, Tack J et al. TRP channels in neurogastroenterology: opportunities for therapeutic intervention. Br J Pharmacol 2011;162:18-37.
17. Holzer P. TRP channels in the digestive system. Curr Pharm Biotechnol 2011;12:24-34.
18. Winston J, Shenoy M, Medley D et al. The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats. Gastroenterology 2007;132:615-27. (Pubitemid 46274656)
19. Chan CL, Facer P, Davis JB et al. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet 2003;361:385-91. (Pubitemid 36164972)
20. Akbar A, Yiangou Y, Facer P et al. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 2008;57:923-9. (Pubitemid 351919527)
21. Akbar A, Yiangou Y, Facer P et al. Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain. Gut 2010;59:767-74.
22. Rozengurt E, Sternini C. Taste receptor signaling in the mammalian gut. Curr Opin Pharmacol 2007;7:557-62. (Pubitemid 350185856)
23. Kusano M, Zai H, Hosaka H et al. New frontiers in gut nutrient sensor research: monosodium L-glutamate added to a high-energy, high-protein liquid diet promotes gastric emptying: a possible therapy for patients with functional dyspepsia. J Pharmacol Sci 2010;112:33-6.
24. Holzer P. Acid sensing by visceral afferent neurones. Acta Physiol (Oxf) 2011;201:63-75.
25. Kaji I, Karaki S, Kuwahara A. Chemosense for luminal environment in the large intestine. Yakugaku Zasshi 2011;131:1691-8.
26. Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol 2010;1:97-105.
27. Yiangou Y, Facer P, Dyer NH et al. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 2001;357:1338-9. (Pubitemid 32441536)
28. O'Malley D, Liston M, Hyland NP et al. Colonic soluble mediators from the maternal separation model of irritable bowel syndrome activate submucosal neurons via an interleukin-6-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 201;300:G241-52.
29. Watson RP, Lilley E, Panesar M et al. Increased prokineticin 2 expression in gut inflammation: role in visceral pain and intestinal ion transport. Neurogastroenterol Motil 2012;24:65-e12.
30. Barbara G, Stanghellini V, De Giorgio R et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693-702. (Pubitemid 38298317)
31. De Winter BY, van den Wijngaard RM, de Jonge WJ. Intestinal mast cells in gut inflammation and motility disturbances. Biochim Biophys Acta 2012;1822:66-73.
32. Surawicz CM. Mechanisms of diarrhea. Curr Gastroenterol Rep 2010;12:236-41.
33. Vriens J, Nilius B, Vennekens R. Herbal compounds and toxins modulating TRP channels. Curr Neuropharmacol 2008;6:79-96. (Pubitemid 351513474)
34. Kano M, Fukudo S, Kanazawa M et al. Changes in intestinal motility, visceral sensitivity and minor mucosal inflammation aft er fasting therapy in a patient with irritable bowel syndrome. J Gastroenterol Hepatol 2006;21:1078-9. (Pubitemid 43823303)
35. Zar S, Mincher L, Benson MJ et al. Food-specific IgG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome. Scand J Gastroenterol 2005;40:800-7. (Pubitemid 40978855)
36. Gibson PR, Shepherd SJ. Personal view: food for thought-western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Aliment Pharmacol Ther 2005;21:1399-409. (Pubitemid 40874156)
37. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol 2010;25:252-8.
38. Clausen MR, Jørgensen J, Mortensen PB. Comparison of diarrhea induced by ingestion of fructooligosaccharide Idolax and disaccharide lactulose: role of osmolarity versus fermentation of malabsorbed carbohydrate. Dig Dis Sci 1998;43:2696-707. (Pubitemid 29034924)
39. Ong DK, Mitchell SB, Barrett JS et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010;25:1366-73.
40. Yao CK, Tan HL, Langenberg DR et al. Abnormal intestinal handling of sorbitol and mannitol in patients with IBS: mechanistic insights and potential clinical implications. J Gastroenterol Hepatol 2011;26 (Suppl 4):70.
41. Marciani L, Cox EF, Hoad CL et al. Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome. Gastroenterology 2010;138:469-77.
42. Shepherd SJ, Parker FC, Muir JG et al. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008;6:765-71.
43. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc 2006;106:631-9.
44. Muir JG, Shepherd SJ, Rosella O et al. Fructan and free fructose content of common Australian vegetables and fruit. J Agric Food Chem 2007;55:6619-27. (Pubitemid 47280038)
45. Muir JG, Rose R, Rosella O et al. Measurement of short-chain carbohydrates in common Australian vegetables and fruits by highperfor mance liquid chromatography (HPLC). J Agric Food Chem 2009;57:554-65.
46. Biesiekierski JR, Rosella O, Rose R et al. Quantification of fructans, galactooligosaccharides and other short-chain carbohydrates in processed grains and cereals. J Hum Nutr Diet 2011;24:154-76.
47. Gearry RB, Irving PM, Barrett JS et al. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis 2009;3:8-14.
48. Barrett JS, Gearry RB, Muir JG et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther 2010;31:874-82.
49. Croagh C, Shepherd SJ, Berryman M et al. Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflamm Bowel Dis 2007;13:1522-8.
50. Barrett JS, Shepherd SJ, Gibson PR. Strategies to manage gastrointestinal symptoms complicating enteral feeding. JPEN J Parenter Enteral Nutr 2009;33:21-6.
51. Halmos EP, Muir JG, Barrett JS et al. Diarrhoea during enteral nutrition is predicted by the poorly absorbed short-chain carbohydrate (FODMAP) content of the formula. Aliment Pharmacol Ther 2010;32:925-33.
52. Halmos EP, Liels KL, Rosella O et al. Enteral nutritional formulas deliver laxative doses of FODMAPs which cannot be predicted by ingredients lists. J Gastroenterol Hepatol 2011;26 (Suppl 4):73.
53. Shepherd SJ, Gibson PR. Food intolerance management plan. Penguin: Melbourne, 2011.
54. Sengupta S, Muir JG, Gibson PR. Does butyrate protect from colorectal cancer? J Gastroenterol Hepatol 2006;21:201-18.
55. Barrett JS, Gibson PR. Development and validation of a comprehensive semi-quantitative food frequency questionnaire that includes FODMAP intake and glycemic index. J Am Diet Assoc 2010;110:1469-76.
56. Allen DH, Van Nunen S, Loblay R et al. Adverse reactions to foods. Med J Aust 1984;141 (5 Suppl):S37-42.
57. Swain A, Scoutter V, Loblay R. RPAH Elimination Diet Handbook. Allergy Unit Royal Prince Alfred Hospital: Sydney, 2011. www.allergy.net.au.
58. Grattan CE. Aspirin sensitivity and urticaria. Clin Exp Dermatol 2003;28:123-7. (Pubitemid 36459612)
59. Suzuki Y, Ra C. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: aspirin modulation of IgE-dependent mast cell activation: role of aspirin-induced exacerbation of immediate allergy. Pharmacol Sci 2009;110:237-44.
60. Raithel M, Baenkler HW, Naegel A et al. Significance of salicylate intolerance in diseases of the lower gastrointestinal tract. J Physiol Pharmacol 2005;56 (Suppl 5):89-102.
61. Gamboa P, Sanz ML, Caballero MR et al. The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin Exp Allergy 2004;34:1448-57. (Pubitemid 39233702)
62. Rodríguez-Trabado A, Cámara-Hijón C, Ramos-Cantariño A et al. Basophil activation test for the in vitro diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity. Allergy Asthma Proc 2008;29:241-9.
63. Celik GE, Schroeder JT, Hamilton RG et al. Effect of in vitro aspirin stimulation on basophils in patients with aspirin-exacerbated respiratory disease. Clin Exp Allergy 2009;39:1522-31.
64. Wahnschaffe U, Ullrich R, Riecken EO et al. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001;121:1329-38. (Pubitemid 33140450)
65. Wahnschaffe U, Schulzke JD, Zeitz M et al. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007;5:844-50. (Pubitemid 47031067)
66. Verdu EF, Huang X, Natividad J et al. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. Am J Physiol Gastrointest Liver Physiol 2008;294:G217-25.
67. Biesiekierski JR, Newnham ED, Irving PM et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol 2011;106:508-14.
68. Newnham ED. Does gluten cause gastrointestinal symptoms in subjects without coeliac disease? J Gastroenterol Hepatol 2011;26 (Suppl 3):132-4.
69. Verdu EF. Editorial: can gluten contribute to irritable bowel syndrome? Am J Gastroenterol 2011;106:516-8.
70. Biesiekierski JR, Newnham ED, Shepherd SJ et al. Self-diagnosis of noncoeliac gluten intolerance by Australian adults: failure to exclude coeliac disease or benefit from a gluten-free diet. J Gastroenterol Hepatol 2011;26 (Suppl 4):70.
71. Stuckey C, Lowdon J, Howdle P. Joint BAPEN and British Society of Gastroenterology Symposium on 'Coeliac disease: basics and controversies'. Dietitians are better than clinicians in following up coeliac disease. Proc Nutr Soc 2009;68:249-51.
72. Campbell AK, Matthews SB, Vassel N et al. Bacterial metabolic "toxins": a new mechanism for lactose and food intolerance, and irritable bowel syndrome. Toxicology 2010;278:268-76.
73. Barrett JS, Irving PM, Shepherd SJ et al. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther. 2009;30:165-74.
74. Nucera G, Gabrielli M, Lupascu A et al. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005;21:1391-5.
75. Brighenti F, Casiraghi MC, Pellegrini N et al. Comparison of lactulose and inulin as reference standard for the study of resistant starch fermentation using hydrogen breath test. Ital J Gastroenterol 1995;27:122-8.
76. Madsen JL, Linnet J, Rumessen JJ. Effect of nonabsorbed amounts of a fructose-sorbitol mixture on small intestinal transit in healthy volunteers. Dig Dis Sci 2006;51:147-53. (Pubitemid 43106353)
77. Piche T, Zerbib F, Varannes SB et al. Modulation by colonic fermentation of LES function in humans. Am J Physiol Gastrointest Liver Physiol 2000;278:G578-84. (Pubitemid 30213124)
78. Piche T, des Varannes SB, Sacher-Huvelin S et al. Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology 2003;124:894-902. (Pubitemid 36389791)
79. Kolida S, Gibson GR. Prebiotic capacity of inulin-type fructans. J Nutr 2007;137 (11 Suppl):2503S-6S. (Pubitemid 350058726)
80. Ledochowski M, Widner B, Murr C et al. Fructose malabsorption is associated with decreased plasma tryptophan. Scand J Gastroenterol 2001;36:367-71. (Pubitemid 32250731)
81. Shepherd SJ, Willet I, Fone D et al. The value of "fructose malabsorption" (FM) diet and fructose breath hydrogen test in patients with irritable bowel syndrome (IBS). J Gastroenterol Hepatol 2003;18 (Suppl):B26.
82. Staudacher HM, Whelan K, Irving PM et al. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet 2011;24:487-95.